Despite research showing remdesivir is ineffective against COVID-19 and can cause high rates of organ failure, the U.S. Food and Drug Administration authorized the experimental antiviral drug for use against COVID-19 — and it’s still being used.
This post was created with our nice and easy submission form. Create your post!
Comments
Loading…